BLS Pharmaceuticals Limited (ASX:BLS)
0.8400
-0.0500 (-5.62%)
Last updated: Jul 21, 2026, 3:18 PM AEST
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 204.68 million as of July 20, 2026. Its market cap has increased by 110.11% in one year.
Market Cap
204.68M
Enterprise Value
202.44M
Revenue
47.95M
Ranking
n/a
PE Ratio
22.43
Stock Price
0.84
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 204.68M, an increase of 552.27%. That is a compound annual growth rate of 14.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 204.68M | 118.98% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 202.35M |
| Betmakers Technology Group | 201.65M |
| Jade Gas Holdings | 200.95M |
| LDR Capital Property Fund | 199.43M |
| Korvest | 199.36M |
| WAM Strategic Value | 199.04M |
| ReadyTech Holdings | 198.94M |
| Altair Minerals | 198.87M |